Clover Health Investments (CLOV) Capital Expenditures (2020 - 2026)

Clover Health Investments has reported Capital Expenditures for 7 years, with the latest figure at $854000.0 in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 361.62% year-over-year to $854000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 109.26% YoY), and the FY2025 full-year result was $2.0 million, up 31.3% from the prior year.
• Capital Expenditures for Q1 2026 stood at $854000.0, up from $597000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $3.9 million in Q4 2022, with the low at -$264000.0 in Q4 2023.
• Historically, Capital Expenditures has averaged $559058.8 across 5 years, with a median of $354000.0 in 2023.
• Annual changes were most pronounced in 2022 — Capital Expenditures surged 1528.99% — and 2023, when it sank 106.81%.
• Clover Health Investments' Capital Expenditures stood at $3.9 million in 2022, then slumped by 106.81% to -$264000.0 in 2023, then jumped by 219.32% to $315000.0 in 2024, then jumped by 89.52% to $597000.0 in 2025, then jumped by 43.05% to $854000.0 in 2026.
• The last three Capital Expenditures figures came in at $854000.0 (Q1 2026), $597000.0 (Q4 2025), and $692000.0 (Q3 2025), per Business Quant data.